CHRNA2 and metabolic dysfunction-associated steatohepatitis: Furthermore, our data using hepatocyte-specific CHRNA2-deficient mice confirmed the direct contribution of hepatic CHRNA2 signaling in HFD plus CCl4-induced MASH development.